HOOK Stock Summary and Trading Ideas (Hookipa Pharma | NASDAQ:HOOK)

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Hookipa Pharma trades on the NASDAQ stock market under the symbol HOOK.

As of January 17, 2025, HOOK stock price climbed to $1.95 with 76,411 million shares trading.

HOOK has a market cap of $23.51 million. This is considered a Sub-Micro Cap stock.

Last quarter Hookipa Pharma reported $5 million in Revenue and -$1.10 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.18.

In the last 3 years, HOOK traded as high as $30.50 and as low as $1.72.

The top ETF exchange traded funds that HOOK belongs to (by Net Assets): VTI, VXF, DFAC, DFAS, DFAT.

HOOK has underperformed the market in the last year with a return of -72.1%, while the SPY ETF gained +28.0%. In the last 3 month period, HOOK fell short of the market, returning -53.2%, while SPY returned +3.0%. However, in the most recent 2 weeks HOOK has outperformed the stock market by returning +4.8%, while SPY returned +1.0%.

HOOK support price is $1.80 and resistance is $2.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HOOK shares will trade within this expected range on the day.